2015 Annual Report
Cross-Strait Technical Exchange and Conference for Medicinal Product Testing
(2) Collaborations in Clinical Trials of Pharmaceuticals
In 2014, medicinal product management departments in both Taiwan and Mainland China finalized
Cross-Strait Pharmaceutical Clinical Trial Cooperation Program
. A pharmaceutical clinical trial
task force was established to accelerate collaboration between Taiwan and Mainland China in
clinical trials for pharmaceuticals and to achieve the objective of minimizing duplicarion of trials.
(3) Developing Joint Inquiry and Review Programs
Open solicitations for a
Cross-Strait Joint Medicinal Product Research and Development Pilot
Cross-Strait Joint Medical Device Research and Development Pilot
were implemented to
establish a collaborative framework model for reviewing medicinal products and medical devices
of Taiwan and Mainland China.
(4) Hosting the
Cross-Strait Conference on Medicinal Product Research and Development
Cross-Strait Conference for Medicinal Product Research and Development
was held in Harbin, Mainland China, on 8 December 2014. Topics such as
collaboration strategy for medicinal product research and development (R&D), establishment of
collaborative platforms for clinical trial centers, simultaneous cross-Strait clinical trials, and
diagnostic (IVD) medical device R&D were discussed. Relevant experiences were exchanged as
(5) Organizing the 2014 Cross-Strait High-level Meeting for Medical and Medicinal Product Safety
Management and Research and Development Work Groups.
2014 Cross-Strait High-level Meeting for Medical and Medicinal Product Safety Management and
Research and Development Work Groups was held on 10 December 2014 in Harbin, Mainland
China, where both sides confirmed the achievement of 2014 and finalized the work plan for 2015.